Key words: Pentraxin, critical care, emergency medicine"> Erenler et al.Clinical Use of Pentraxin 3: A Review – Direct Research Journal of Health and Pharmacology
Erenler et al.Clinical Use of Pentraxin 3: A Review Erenler et al.Clinical Use of Pentraxin 3: A Review – Direct Research Journal of Health and Pharmacology
Review

Clinical Use of Pentraxin 3: A Review

Ali Kemal Erenler1*

OÄŸuzhan YÄcel2

Ahmet BaydÄn3

Article Number: DRJA38706272
DOI: https://doi.org/10.26765/DRJHP.2017.6272
ISSN: 2449-0814

Vol.5 (2), pp. 7-13, October 2017

Copyright © 2017
Author(s) retain the copyright of this article


Abstract

Pentraxin 3 (PTX3) is a novel marker of the acute-phase inflammatory response, belonging to the PTX protein family. It also plays a role in innate immunity. It is known to be produced at the site of infection or inflammation by macrophages, monocytes, denditic cells and tissue cells. Increased levels of PTX3 in the circulating blood have been found to be involved in many pathologies such as coronary artery, respiratory system, renal, hematological, neurological and inflammatory diseases. In this review, we aimed to clarify the biochemical structure of PTX3 and reveal its etiological and diagnostic importance in diseases frequently seen in the Emergency Department.

Key words: Pentraxin, critical care, emergency medicine
 Received: September 10, 2017  Accepted: September 29, 2017  Published: October 6, 2017



Copyright © 2026 Direct Research Journal of Health and Pharmacology

Direct Research Center  logo

Direct Research Center publishes peer-reviewed, open access online journals in areas of Agriculture and Food science, Biology and Biotechnology, Health and Pharmacology, Chemistry and Material science, Engineering and Information Technology and Social Science and Educational Studies.


Creative Commons
Open Access